Litcius/Paper detail

Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review

Alzhraa Salah Abbas, Nicole Hardy, Sherief Ghozy, Mahmoud Dibas, Geeta Paranjape, Kirk W. Evanson, Natalie L. Reierson, Kathryn Cowie, Shelby Kamrowski, Scarlett Schmidt, Yutao Tang, Amber R. Davis, Jillienne C. Touchette, Kevin M. Kallmes, Ameer E Hassan, Ranita Tarchand, Mansi Mehta, John M. Pederson, Mohamed A. Abdelmegeed

2022Clinical Neurology and Neurosurgery22 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Myasthenia gravisInternal medicinePrednisoneAzithromycinMechanical ventilationDiabetes mellitusDiseaseMicrobiologyAntibioticsBiologyEndocrinologyInfectious disease (medical specialty)Myasthenia Gravis and ThymomaLong-Term Effects of COVID-19Adrenal Hormones and Disorders
Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review | Litcius